Key result
The missense variant CCDC92S70C was associated with increased leg fat mass and reduced visceral fat, while SPATA20K422R and UQCC1R51Q were associated with reduced arm fat mass.
Why the study?
Do specific protein-coding gene variants influence regional fat depot masses?
Meta-Analysis (n=17,212)
Yes
Do specific protein-coding gene variants influence regional fat depot masses?
Effect estimate: β = -0.063 (visceral fat for CCDC92S70C)
p-value: p=1.3x10^-7
Different fat compartments are regulated by distinct genetic factors, providing a more nuanced understanding of cardiometabolic risk beyond waist-to-hip ratio.
Suggests distinct genetic control of fat compartments; leaves open clinical utility for cardiometabolic risk stratification.
Waist-to-hip ratio (WHR) is a prominent cardiometabolic risk factor that increases cardio-metabolic disease risk independently of BMI and for which multiple genetic loci have been identified. However, WHR is a relatively crude proxy for fat distribution and it does not capture all variation in fat distribution. We here present a study of the role of coding genetic variants on fat mass in 6 distinct regions of the body, based on dual-energy X-ray absorptiometry imaging on more than 17k participants. We find that the missense variant CCDC92S70C, previously associated with WHR, is associated specifically increased leg fat mass and reduced visceral but not subcutaneous central fat. The minor allele-carrying transcript of CCDC92 is constitutively more highly expressed in adipose tissue samples. In addition, we identify two coding variants in SPATA20 and UQCC1 that are associated with arm fat mass. SPATA20K422R is a low-frequency variant with a large effect on arm fat only, and UQCC1R51Q is a common variant reaching significance for arm but showing similar trends in other subcutaneous fat depots. Our findings support the notion that different fat compartments are regulated by distinct genetic factors.
No takes yet. Share an insight, caveat, or question.
Neville et al. (2019) conducted a meta-analysis in Regional fat distribution (n=17,212). Protein-coding gene variants (CCDC92S70C, SPATA20K422R, UQCC1R51Q) vs. Non-carriers / major allele was evaluated on DXA-derived fat mass in 6 body fat regions (inverse normally transformed residuals) (β = -0.063 (visceral fat for CCDC92S70C), p=1.3x10^-7). The missense variant CCDC92S70C was associated with increased leg fat mass and reduced visceral fat, while SPATA20K422R and UQCC1R51Q were associated with reduced arm fat mass.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: